Compara mètodes

	CushQoL: Qüestionari de Qualitat de Vida de la Síndrome de Cushing	AGHDA: Avaluació de la Deficiència d'Hormona del Creixement en Adults
Camp	Endocrinologia	Endocrinologia
Família	Process / pipeline	Process / pipeline
Any d'origen	2008	2000
Autor original	Sergio Webb, María D. Bernal, Juan M. Rivera-Caravaca	Anthony Hunt, Garry Werther, Peter Wrightson
Tipus	Patient self-report questionnaire	Patient self-report questionnaire
Font seminal	Webb, S. M., Bernal, M. D., Rivera-Caravaca, J. M., & Córdoba-Soriano, J. G. (2008). Development and validation of CushQoL, a disease-specific quality of life questionnaire in Cushing's syndrome. J Clin Endocrinol Metab, 93(5), 1751-1759.	Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346.
Àlies	Cushing QoL, CS-QoL	AGHDA-25
Relacionats	3	3
Resum	CushQoL is a disease-specific 12-item quality of life questionnaire developed to assess the multidimensional impacts of Cushing's syndrome—a severe endocrine disorder characterized by excess cortisol production. Developed by Webb and colleagues in 2008, it captures physical symptoms (fatigue, weight gain, weakness, hirsutism), psychological manifestations (depression, anxiety, cognitive impairment), and social/occupational dysfunction unique to Cushing's syndrome. It is the standard outcome measure for assessing quality of life improvement following curative therapy.	The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy.